G9 Ventures — 2020 Investments

1 investments dated 2020 · listed companies and verified rows first · show all

Carawaycarawaytx.com in 𝕏May 2020 · $5.3Macquired by Merck

Caraway Therapeutics was a preclinical biopharmaceutical company developing small-molecule therapies modulating lysosomal function to treat neurodegenerative and rare diseases.

BiotechHealthtech

Co-investorsDementia Discovery Fund Eisai Innovation, Inc.McCarthy Capital MRL Ventures Fund SV Health Investors AbbVie +9 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.